Singapore, July 21 -- China-based Fangzhou Inc., a leader in internet healthcare solutions, has signed a Memorandum of Understanding (MoU) with Novo Nordisk, a leading global healthcare company.Leveraging its artificial intelligence (AI) application services, innovative treatment solutions, and convenient pharmaceutical services, Fangzhou will collaborate with Novo Nordisk on managing serious chronic diseases, such as diabetes and obesity.

By leveraging Novo Nordisk's expertise and innovative products in diabetes and obesity treatment, Fangzhou plans to employ its smart healthcare ecosystem and robust technology infrastructure to create a comprehensive health management service. This will include medication guidance, reminders, efficacy ...